SCHEMBL25859550

SCHEMBL25859550

CCOCOCC#Cc1ccc(B2OC(C)(C)C(C)(C)O2)c(OCOCC)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25260899 0.88 EGFR (0.30)
SCHEMBL30101076 0.83 TRPV4 (0.41)
SCHEMBL28934476 0.83 TRPV4 (0.41)
SCHEMBL25300289 0.82 CHRNB2 (0.33)
SCHEMBL25857918 0.81
SCHEMBL28934910 0.77 UCHL1 (0.39)
SCHEMBL30517789 0.76
SCHEMBL28934341 0.76 LPL (0.30)
Cyclopentane SCHEMBL25256366 0.75
SCHEMBL25254463 0.75 MEN1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131277-A1 NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF 药捷安康(南京)科技股份有限公司 2023-07-13 WO disclosed
CN-116410140-A NLRP3 inflammation corpuscle inhibitor and application thereof 药捷安康(南京)科技股份有限公司 2023-07-11 CN disclosed